The Latest Headlines at American Banking and Market News
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut to $466.00
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its target price cut by stock analysts at UBS Group from $498.00 to $466.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has a “buy”... More of this article »
Gilead Sciences (NASDAQ:GILD) PT Lowered to $75.00
Gilead Sciences (NASDAQ:GILD – Get Free Report) had its target price lowered by equities research analysts at UBS Group from $81.00 to $75.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has a... More of this article »-logo-1200x675.png?v=20240125142140&w=240&h=220&zc=2){kind=logo}
Telefonaktiebolaget LM Ericsson (publ) (NASDAQ:ERIC) Price Target Cut to $5.58
Telefonaktiebolaget LM Ericsson (publ) (NASDAQ:ERIC – Get Free Report) had its price target dropped by stock analysts at JPMorgan Chase & Co. from $5.81 to $5.58 in a research report issued to clients and investors on Wednesday,... More of this article »
Federated Hermes (NYSE:FHI) PT Raised to $47.00 at JPMorgan Chase & Co.
Federated Hermes (NYSE:FHI – Get Free Report) had its price target hoisted by equities research analysts at JPMorgan Chase & Co. from $46.00 to $47.00 in a report issued on Wednesday, Benzinga reports. The brokerage presently... More of this article »
Truist Financial Lowers Marinus Pharmaceuticals (NASDAQ:MRNS) Price Target to $10.00
Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) had its price objective cut by equities researchers at Truist Financial from $25.00 to $10.00 in a research report issued on Wednesday, Benzinga reports. The firm currently... More of this article »
J.B. Hunt Transport Services (NASDAQ:JBHT) PT Lowered to $204.00
J.B. Hunt Transport Services (NASDAQ:JBHT – Get Free Report) had its target price decreased by JPMorgan Chase & Co. from $209.00 to $204.00 in a report issued on Wednesday, Benzinga reports. The firm presently has an “overweight”... More of this article »
JPMorgan Chase & Co. Lowers Darling Ingredients (NYSE:DAR) Price Target to $62.00
Darling Ingredients (NYSE:DAR – Get Free Report) had its price target reduced by stock analysts at JPMorgan Chase & Co. from $66.00 to $62.00 in a note issued to investors on Wednesday, Benzinga reports. The firm currently... More of this article »
JPMorgan Chase & Co. Increases AngloGold Ashanti (NYSE:AU) Price Target to $31.00
AngloGold Ashanti (NYSE:AU – Get Free Report) had its price target hoisted by investment analysts at JPMorgan Chase & Co. from $23.00 to $31.00 in a research note issued to investors on Wednesday, Benzinga reports. The... More of this article »
JPMorgan Chase & Co. Increases Harmony Gold Mining (NYSE:HMY) Price Target to $4.90
Harmony Gold Mining (NYSE:HMY – Get Free Report) had its price objective raised by equities research analysts at JPMorgan Chase & Co. from $3.20 to $4.90 in a note issued to investors on Wednesday, Benzinga reports. The... More of this article »
Morgan Stanley Increases EQT (NYSE:EQT) Price Target to $49.00
EQT (NYSE:EQT – Get Free Report) had its price objective lifted by equities researchers at Morgan Stanley from $37.00 to $49.00 in a research note issued on Wednesday, Benzinga reports. The firm currently has an “overweight”... More of this article »
Invesco (NYSE:IVZ) PT Raised to $17.00
Invesco (NYSE:IVZ – Get Free Report) had its price objective boosted by investment analysts at Morgan Stanley from $16.00 to $17.00 in a report released on Wednesday, Benzinga reports. The firm currently has an “equal... More of this article »
Morgan Stanley Increases Franklin Resources (NYSE:BEN) Price Target to $25.00
Franklin Resources (NYSE:BEN – Get Free Report) had its target price boosted by equities research analysts at Morgan Stanley from $24.00 to $25.00 in a research report issued to clients and investors on Wednesday, Benzinga reports.... More of this article »
Janus Henderson Group (NYSE:JHG) PT Raised to $33.00 at Morgan Stanley
Janus Henderson Group (NYSE:JHG – Get Free Report) had its price objective hoisted by investment analysts at Morgan Stanley from $30.00 to $33.00 in a report issued on Wednesday, Benzinga reports. The brokerage currently has... More of this article »